Диссертация (1173248), страница 16
Текст из файла (страница 16)
– P. 263–284.119. Kleihues, P. Pathology and genetics of tumours of the nervous system. / WorldHealth Organization classification of tumors // IARC Press. - 2000.120. Ouwerkerk, R. Tissue sodium concentration in human brain tumors asmeasured with 23Na MR imaging / R. Ouwerkerk, K. B. Bleich, J. S. Gillen et al.// Radiology.
– 2003. – Vol. 227(2). – P. 529–537.109121. Pallud, J. Prognostic significance of imaging contrast enhancement for WHOgrade II gliomas / J. Pallud, L. Capelle, L. Taillandier et al. // Neuro-oncology. 2009. – Vol. 11. – P. 176–82.122. Parnetti, L. Proton magnetic resonance spectroscopy can differentiateAlzheimer's disease from normal aging / L. Parnetti, R. Tarducci, O.
Presciutti et al.// Mech Ageing Dev. – 1997. – Vol. 97. – P. 9-14.123. Pereira, A. C. Measurement of initial N-acetyl aspartate concentration bymagnetic resonance spectroscopy and initial infarct volume by MR1 predictsoutcome in patients with middle cerebral artery territory infarction / A. C. Pereira,D. E. Saunders, V. L. Doyle et al. // Stroke. – 1999. – Vol. 30. – P. 1577-1582.124. Pfefferbaum, A. In vivo spectroscopic quantification of the N-acetyl moiety,creatine, and choline from large volumes of brain gray and white matter: effects ofnormal aging / A. Pfefferbaum, E. Adalsteinsson, D. Spielman // Magn Reson Med.– 1999. – Vol.
41(2). – P. 276–284.125. Porto, L. Spectroscopy of untreated pilocytic astrocytomas: do children andadults share some metabolic features in addition to their morphologic similarities? /L. Porto, M. Kieslich, K. Franz et al. // Official Journal ofthe International Societyfor Pediatric Neurosurgery. – 2010.
– Vol. 26. – P. 801–806.126. Pouwels, P. Regional metabolite concentrations in human brain as determinedby quantitative localized proton MRS / P. Pouwels, J. Frahm // Magn Reson Med. –1998. – Vol. 39(1). – P. 53-60.127. Preul, M. C. Accurate, noninvasive diagnosis of human brain tumors by usingproton magnetic resonance spectroscopy / M. C. Preul, Z. Caramanos, D. L. Collinset al. // Nat Med. – 1996.
– Vol. 2(3). – P. 323–325.128. Preul, M. C. Magnetic resonance spectroscopy guided brain tumor resection:differentiation between recurrent glioma and radiation change in two diagnosticallydifficult cases / M. C. Preul, R. Leblanc, Z. Caramanos et al. // Can J Neurol Sci. –1998. – Vol. 25(1). – P.
13–22.110129. Raza, S. M. Necrosis and glioblastoma: a friend or a foe? A review and ahypothesis / S. M. Raza, F. F, Lang, B. B. Aggarwal et al. // Neurosurgery. - 2002.– Vol. 51. – P. 2–12.130. Remy, C. Evidence that mobile lipids detected in rat brain glioma by 1Hnuclear magnetic resonance correspond to lipid droplets / C. Remy, N. Fouilhe, I.Barba et al. // Cancer Research. – 1997.
– Vol. 57. – P. 407–414.131. Ricci, P. E. Effect of voxel position on single-voxel MR spectroscopy findings/ P. E. Ricci, A. Pitt, P. J. Keller et al. // AJNR Am J Neuroradiol. – 2000. – Vol.21(2). – P. 367–374.132. Rose, S. E. A 1H MRS study of probable Alzheimer’s disease and normalaging: implications for longitudinal monitoring of dementia progression / S. E. Rose,G. I. de Zubicaray, D. Wang et al. // Magn Reson Imaging. – 1999.
– Vol. 17(2). –P. 291–299.133. Sabatier, J. Characterization of choline compounds with in vitro 1H magneticresonance spectroscopy for the discrimination of primary brain tumors / J. Sabatier,V. Gilard, M. Malet-Martino et al. // Investigative Radiology. – 1999. – Vol. 34. –P. 230–235.134. Saraf-Lavi, E. Proton MR spectroscopy of gliomatosis cerebri: case report ofelevated myoinositol with normal choline levels / E. Saraf-Lavi, B.
C. Bowen, P. M.Pattany et al. // AJNR: American Journal of Neuroradiology. – 2003. – Vol. 24. – P.946–951.135. Saraswathy, S. Evaluation of MR markers that predict survival in patients withnewly diagnosed GBM prior to adjuvant therapy / S. Saraswathy, F. W. Crawford,K. R. Lamborn et al. // Journal of Neuro-oncology. – 2009. – Vol. 91. – P. 69–81.136. Scholzen, T. The Ki-67 protein: from the known and the unknown / T.Scholzen, J. Gerdes // Journal of Cellular Physiology. – 2000. – Vol. 182. – P. 311–322.137. Schuff, N.
Changes of hippocampal N-acetyl aspartate and volume inAlzheimer’s disease. A proton MR spectroscopic imaging and MRI study / N.111Schuff, D. Amend, F. Ezekiel et al. // Neurology. – 1997. – Vol. 49(6). – P. 1513–1521.138. Schwartzbaum, J. A. Epidemiology and molecular pathology of glioma / J. A.Schwartzbaum, J. L. Fisher, K. D. Aldape et al.
// Nature clinical practice.Neurology. – 2006. – Vol. 2. – P. 494–503.139. Senft, C. Diagnostic value of proton magnetic resonance spectroscopy in thenoninvasive grading of solid gliomas: comparison of maximum and mean cholinevalues / C. Senft, E. Hattingen, U. Pilatus et al. // Neurosurgery. – 2009. – Vol. 65(5).– P. 908–913.140. Shaw, E. Prospective randomized trial of low- versus high-dose radiationtherapy in adults with supratentorial low-grade glioma / E. Shaw, R. Arusell, B.Scheithauer et al. // Journal of Clinical Oncology.
– 2002. – Vol. 20. – P. 2267–2276.141. Shimizu, H. Correlation between choline level measured by proton MRspectroscopy and Ki-67 labeling index in gliomas / H. Shimizu, T. Kumabe, R.Shirane et al. // AJNR: American Journal of Neuroradiology. – 2000. - Vol. 21. – P.659–665.142. Sibtain, N. A. The clinical value of proton magnetic resonance pectroscopy inadult brain tumours / N. A. Sibtain, F. A. Howe, D. E. Saunders // Clinical Radiol. 2007. - Vol.
62. - P. 109–119.143. Sijens, P. E. Clinical Magnetic Resonance Spectroscopy / P. E. Sijens, M.Oudkerk // Imaging decisions. - 2005. – Vol. 1. - P. 23–38.144. Sivák, Š. Proton magnetic resonance spectroscopy in patients with early stagesof amyotrophic lateral sclerosis / S.
Sivák, M. Bittšanský, E. M. Kurča et al. //Neuroradiology. – 2010. – Vol. 52(12). – P. 1079-1085145. Soares, D. P. Magnetic resonance spectroscopy of the brain: review ofmetabolites and clinical applications / D. P. Soares, M. Law // Clinical Radiology. 2009. – Vol.
64. – P. 12–21.146. Stadlbauer, A. Preoperative grading of gliomas by using metabolitequantification with high-spatial-resolution proton MR spectroscopic imaging / A.112Stadlbauer, S. Gruber, C. Nimsky et al. // Radiology. – 2006. – Vol. 238. – P. 958–69.147. Stevenson, V.L. Primary and transitional progressive MS: a clinical and MRIcross-sectional study / V. L.
Stevenson, D. H. Miller, M. Rovaris et al. //Neurology1999. – Vol. 52(4). – P. 839-845.148. Stromillo, M. Brain metabolic changes suggestive of axonal damage inradiologically isolated syndrome / M. Stromillo, A. Giorgio, F. Rossi et al.// Neurology. – 2013. – Vol. 80(23). – P. 2090-2094.149. Sutton, L. N. Proton magnetic resonance spectroscopy of pediatric braintumors / L. N. Sutton, Z. Wang, D. Gusnard et al. // Neurosurgery. – 1992.
– Vol.31. – P. 195–202.150. Tate, A. R. Towards a method for automated classification of 1H MRS spectrafrom brain tumours / A. R. Tate, J. R. Griffiths, I. Martinez-Perez et al. // NMRBiomed. – 1998. – Vol. 11(4–5). – P. 177–191.151. Tate, A. R. Automated classification of short echo time in in vivo 1H braintumor spectra: a multicenter study / A. R. Tate, C. Majos, A.
Moreno et al. // MagnReson Med. – 2003. – Vol. 49(1). – P. 29–36.152. Uhm, J. H. Glioma invasion in vitro: regulation by matrix metalloprotease-2and protein kinase C / J. H. Uhm, N. P. Dooley, J. G. Villemure et al. // Clinical &Experimental Metastasis. – 1996. – Vol.
14. – P. 421–433.153. Urenjak, J. Proton nuclear magnetic resonance spectroscopy unambiguouslyidentifies different neural cell types / J. Urenjak, S. R. Williams, D. G. Gadian // TheJournal of Neuroscience: The Official Journal of the Society for Neuroscience. –1993. – Vol.13. – P. 981–989.154. Venkatesh, S. K. Spectroscopic increase in choline signal is a nonspecificmarker for differentiation of infective/inflammatory from neoplastic lesions of thebrain / S. K. Venkatesh, R. K.
Gupta, L. Pal et al. // Journal of Magnetic ResonanceImaging: JMRI. – 2001. – Vol. 14. – P. 8–15.113155. Vives, K. P. Complications and expected outcome of glioma surgery / K. P.Vives, J. M. Piepmeier // Journal of Neuro-oncology. – 1999. – Vol. 42. – P. 289–302.156. Wang, Y. Differentiation of metabolic concentrations between gray matterand white matter of human brain by in vivo 1H magnetic resonance spectroscopy /Y. Wang, S. J. Li // Magnetic Resonance in Medicine: Official Journal of the Societyof Magnetic Resonance in Medicine.
– 1998. – Vol. 39. – P. 28–33.157. Warren, K. E. Proton magnetic resonance spectroscopic imaging in childrenwith recurrent primary brain tumors / K. E. Warren, J. A. Frank, J. L. Black et al. //Journal of Clinical Oncology: Official Journal of the American Society of ClinicalOncology. – 2000. – Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
